
Sign up to save your podcasts
Or


We saw the amazing performance of Pfizer and Moderna's two mRNA COVID vaccines in their RCTs. As encouraging as trial performance is, we always want to know how those numbers hold up under large-scale, real-world pragmatic conditions. Well, we now have three new pieces of information on that. And, for the cherry on top, we get evidence of performance against asymptomatic infection! Dr. Jarvis does a quick review of the latest evidence on vaccine performance.
By Long Pause Media | FlightBridgeED4.9
131131 ratings
We saw the amazing performance of Pfizer and Moderna's two mRNA COVID vaccines in their RCTs. As encouraging as trial performance is, we always want to know how those numbers hold up under large-scale, real-world pragmatic conditions. Well, we now have three new pieces of information on that. And, for the cherry on top, we get evidence of performance against asymptomatic infection! Dr. Jarvis does a quick review of the latest evidence on vaccine performance.

123 Listeners

1,866 Listeners

385 Listeners

21 Listeners

103 Listeners

227 Listeners

261 Listeners

269 Listeners

43 Listeners

147 Listeners

43 Listeners

19 Listeners

895 Listeners

211 Listeners

6 Listeners